US Patent 7195759 Therapeutic uses of glandular kallikrein
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Edris Sabbadini0
Eva Nagy0
Istvan Berczi0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+326 characters)
Article
Patent abstract
An immunosuppressive peptide of 40 kDa molecular weight, isolated from the submandibular glands (SMG*) of rats, had the capacity to suppress immune reactions upon parenteral administration to rats and mice. The peptide was identified as glandular kallikrein (K1) by partial sequencing and by enzymatic activity.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07195759 Therapeutic uses of glandular kallikrein US Patent 7195759 Therapeutic uses of glandular kallikrein
Infobox
Patent Number
071957590
Patent Number
71957590
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071957590
Date of Patent
March 27, 2007
0Patent Application Number
101626970
Date Filed
June 6, 2002
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07195759 Therapeutic uses of glandular kallikrein
Infobox
Is a
Patent jurisdiction
Patent number
07195759
Date of patent
March 27, 2007
Patent application number
10162697
Date Filed
June 6, 2002
Patent primary examiner
Find more entities like US Patent 7195759 Therapeutic uses of glandular kallikrein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.